Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    n/a
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    n/a

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Balance Sheet

Assets, liabilities, and equity

31 accounts · 1 year

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	Trend
Assets
Cash and Cash Equivalents	$1.8B
Short Term Investments	$0
Accounts Receivable	$1.5B
Inventory	$1.0B
Prepaid Expenses	$293.0M
Other Current Assets	$293.0M
Total Current Assets	$4.6B
Property,Plant and Equipment	$2.0B
Operating Lease Assets	$183.0M
Goodwill	$4.5B
Intangible Assets	$445.0M
Long Term Investments	$133.0M
Other Noncurrent Assets	$1.1B
Total Assets	$12.7B
Liabilities
Accounts Payable	$570.0M
Accrued Liabilities	$443.0M
Deferred Revenue	$624.0M
Current Portion of Long Term Debt	$304.0M
Total Current Liabilities	$2.3B
Long Term Debt	$3.0B
Deferred Revenue Noncurrent	$624.0M
Other Noncurrent Liabilities	$463.0M
Total Liabilities	$6.0B
Equity
Preferred Stock	$0
Common Stock	$3.0M
Additional Paid In Capital	$5.6B
Retained Earnings	$1.4B
Treasury Stock	$0
Accumulated Other Comprehensive Income	$-226.0M
Total Stockholders Equity	$6.7B
Total Liabilitiesand Equity	$12.7B

Income Statement

Revenue, expense, and profitability

20 accounts · 1 year

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	$6.9B
Expenses Cost of Revenue	$3.3B
Expenses Research and Development	$455.0M
Expenses Selling,General and Administrative	$1.7B
Expenses Depreciation and Amortization	$288.0M
Expenses Share Based Compensation	$128.0M
Expenses Restructuring and Asset Impairment	$82.0M
Expenses Operating Expenses	$5.5B
Other Income Expense Operating Income	$1.5B
Other Income Expense Interest Income	$62.0M
Other Income Expense Interest Expense	$112.0M
Other Income Expense Other Income/expense	$6.0M
Other Income Expense Income Before Tax	$1.4B
Income Tax Income Tax Expense	$132.0M
net Income net Income	$1.3B
net Income Comprehensive Income	$1.4B
Earnings Per Share Basic Eps	$5
Earnings Per Share Diluted Eps	$5
Earnings Per Share Weighted Average Shares Basic	$284.0M
Earnings Per Share Weighted Average Shares Diluted	$285.0M

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 1 year

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	Trend
CashFlow
Operating Activities net Income	$1.3B
Operating Activities Depreciation and Amortization	$288.0M
Operating Activities Stock Based Compensation	$128.0M
Operating Activities Deferred Income Taxes	$-130.0M
Operating Activities Changes In Operating Assets and Liabilities	$833.0M
Operating Activities net Cash From Operating Activities	$1.6B
Investing Activities Capital Expenditures	$407.0M
Investing Activities Business Acquisitions	$-4.0M
Investing Activities Purchases of Investments	$0
Investing Activities net Cash From Investing Activities	$-394.0M
Financing Activities Proceeds From Debt	$4.0M
Financing Activities Repayment of Debt	$3.0M
Financing Activities Repurchase of Common Stock	$425.0M
Financing Activities Dividends Paid	$282.0M
Financing Activities Proceeds From Stock Issuance	$72.0M
Financing Activities Tax Withholding On Stock Based Compensation	$29.0M
Financing Activities Other Financing Activities	$0
Financing Activities net Cash From Financing Activities	$-715.0M
Cash Reconciliation Effect of Exchange Rate On Cash	$9.0M
Cash Reconciliation net Change In Cash	$459.0M
Cash Reconciliation Cash At Beginning of Period	$1.8B
Cash Reconciliation Cash At End of Period	$1.8B

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	+52.4%
Operating margin	+21.3%
Net margin	+18.8%
FCF margin	+16.6%
Growth
Revenue CAGR (3y)	+0.5%
Returns
ROE	+19.3%
ROA	+10.2%
ROIC	+16.2%
Liquidity
Current ratio	1.96x
Quick ratio	1.40x
Leverage
D/E	0.89x
Interest coverage	13.21x
Efficiency
Asset turnover	0.55x
Cash conversion cycle	+128d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched